Xcout IntelMedpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Subscribe to see Medpace Holdings, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Medpace Holdings, Inc. at a glance
Medpace Holdings, Inc. is a pharmaceutical services company headquartered in Cincinnati, United States. It is publicly listed (MEDP) with a market capitalisation of $17.6B. Xcout tracks 24 named people at Medpace Holdings, Inc., including August James Troendle (CEO, President & Chairman).
Medpace Holdings, Inc. leadership
- August James TroendleCEO, President & Chairman
- August Troendle, MDPresident, Chief Executive Officer, and Chairman of the Board of Directors
- Kevin BradyChief Financial Officer & Treasurer
- Stephen EwaldChief Compliance Officer, General Counsel & Corporate Secretary
- John T. WynneChief Business Officer
- Reinilde HeyrmanChief Medical Officer of Medical Department
18 more named people on record for Medpace Holdings, Inc., with roles, board committees and tenure — see the full roster →
Medpace Holdings, Inc. competitors
A few of Medpace Holdings, Inc.'s closest competitors — see the full list of competitors and alternatives →
Parexel is a contract research organization (CRO) that provides comprehensive biopharmaceutical services to the life sciences industry. The company offers end-to-end solutions spanning portfolio optimization, regulatory strategy, Phase I-IV clinical trials, market access planning, and post-approval lifecycle management.
Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization (CRO) providing clinical trial and research services for pharmaceutical, biotechnology, and medical device companies. The company supports clients throughout the product development lifecycle, offering services such as preclinical development, clinical monitoring, regulatory affairs, data management, and medical device trials.
ICON plc is a clinical research organization (CRO) that provides outsourced clinical, consulting, and commercial services to pharmaceutical, biotechnology, medical device, and government organizations. The company assists clients with drug development, clinical trials, laboratory services, regulatory affairs, and market access strategies.
Evidenze is a contract research organization (CRO) that provides full-service clinical research, digital health solutions, and pharmacovigilance services. The company serves biotech and small-to-medium pharmaceutical companies by offering study start-up, clinical operations, data management, biostatistics, and medical writing services to accelerate clinical trials and optimize study outcomes.
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Shanghai Medicilon Inc. is a contract research organization (CRO) that provides comprehensive drug discovery, chemistry, biology, CMC development, and preclinical research services. The company serves pharmaceutical and biotechnology innovators by offering integrated solutions spanning chemical synthesis, pharmacology, ADME/DMPK, and safety assessment to advance drug candidates toward IND filings.
Get Medpace Holdings, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Medpace Holdings, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Medpace Holdings, Inc. in Xcout Intel
- 24 named people with titles, LinkedIn and board committees
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access